The Gut-Brain-Liver Link in Obesity: A Conversation Inside Your Body

Obesity influences liver health, and liver health can also affect metabolic pathways that drive weight gain, creating a bidirectional relationship. Fatty liver is a common aspect of obesity, but in many cases, that relationship progresses without clear warning signs. In the middle of this internal dialogue are the tiny microbes living in the gastrointestinal tract.

Researchers are uncovering incredible secrets about our digestive tract. It turns out that the trillions of microbes living in our gut are actively talking to the rest of our body. From metabolism to immunity, energy balance to appetite, the gut microbiome influences how we live, eat, and even think. Our bodies are holding complex internal conversations.

Now, science is zooming in on one of the most fascinating conversations happening inside us: the dialogue between the gut, the brain, and the liver. This three-way connection, called the gut-brain-liver axis, is proving to be an important aspect in understanding obesity and liver health. It could explain why weight gain, liver disease, and metabolic problems are so often intertwined and why interventions like diet, lifestyle changes, and bariatric surgery can have ripple effects far beyond the scale.

What is the Gut-Brain-Liver Axis?

The gut-liver-brain axis is a multi-directional communication network linking three major organs: the gut, the liver, and the brain. These organs continuously send signals to each other, affecting each other’s function through neural, endocrine, immune, and metabolic pathways. Scientists have taken an increasing interest in the gut microbiome as part of this network. It produces metabolites that regulate energy homeostasis, immune responses, and metabolic processes, effectively acting like a hub.¹

Communication between the gastrointestinal (GI) tract and the brain happens both directly and indirectly. The vagus nerve is responsible for direct signaling. Indirect pathways use immune and neuroendocrine (nerve-hormone) mechanisms. The vagus nerve is a major communication pathway within the autonomic nervous system that transmits signals between the brain and multiple organs, including the gut, heart, and lungs. These signals influence appetite, food reward, energy balance, and fat storage – all components of obesity. All of this internal communication is bidirectional: the brain communicates back to the gut, and the liver integrates signals from both, creating a continuous loop. The nervous system, hormones, immune factors, and microbial metabolites are all contributors to the dialogue.²

The gut-brain-liver axis runs through the central nervous system (CNS), the autonomic nervous system (ANS), the enteric nervous system (ENS, referred to as the “second brain”), and enteroendocrine cells (hormone-secreting gatekeepers) lining the gut. ³Together, they regulate energy, metabolism, and fat storage. This is a direct connection to understanding the internal workings of obesity as well as liver disease, and a big part of realizing it as a chronic disease rather than simply a “lifestyle problem.”

Putting it All Together

If it’s so important for this system to constantly communicate, what happens when it breaks down?

One of the most consistent findings in obesity is something called gut dysbiosis, an imbalance in the gut microbiome. Instead of a diverse and flourishing ecosystem that’s stable, at some point there was a shift that created more pro-inflammatory bacteria and fewer beneficial ones. Based on what we’re learning about the interactions between the GI system and the rest of the body, this affects how signals are sent throughout the entire gut-brain-liver axis.³

At the same time, excess body fat, particularly visceral fat, isn’t just on standby taking up space. It becomes metabolically active and starts releasing inflammatory signals into the bloodstream. This creates a state of chronic, low-grade inflammation that interferes with how the body regulates energy, glucose, and fat.³

Now layer those two things together. The result of disrupted gut signaling and systemic inflammation is a cycle that drives weight gain, impairs metabolism, and stresses the liver. Even when someone is actively trying to manage their weight, signals that normally help regulate hunger and fullness can become unreliable, making it difficult to maintain a healthy metabolism.

It’s important here to also mention that what we eat has a huge impact on this dysfunctional process. Diet patterns that are high in processed and ultra-processed foods can disrupt the microbiome and promote inflammation, while diets rich in fiber and whole foods help support microbial balance. At the same time, stress and emotional factors feed into this system, influencing eating behaviors through the same gut-brain pathways.⁴

Now enter the liver. Metabolic dysfunction-associated steatotic liver disease (MASLD), or what many still call fatty liver disease, is now one of the most common liver conditions worldwide – it affects an estimated 38% of adults and continues to rise.⁵

MASLD develops when excess fat accumulates in the cells of the liver. Excess fat in the liver is common in patients with obesity, and over time, it can progress to inflammation (MASH), fibrosis, cirrhosis, and even liver cancer if left unchecked.

Disruptions in the gut-brain-liver axis contribute to increased liver fat production, systemic inflammation, and insulin resistance.⁶ Obesity and fatty liver disease are tied to a broader set of risks, including cardiovascular disease, kidney disease, and type 2 diabetes. When abdominal obesity and fatty liver occur together, the risk of complications and even long-term mortality goes up significantly.⁷

There’s also a two-way relationship here. Obesity contributes to liver disease, but liver dysfunction can also feed back into metabolic disruption, making weight management even more difficult.⁸ Obesity is a complex, multifactorial disease, influencing and influenced by multiple systems in the body – primarily metabolic, neurological, immune, and endocrine. Chronic obesity is the fallout from a system that’s out of sync, where signals between the gut, brain, and liver are no longer working the way they should.

Mitigating Damage

Is it possible to bring this dysfunction back into balance?

To some degree, yes. And it takes intention, consistency, and the right tools.

A lot of what drives liver damage in obesity comes back to the same core issues: excess fat accumulation, chronic inflammation, and insulin resistance. So, many of the strategies that help the liver are the same ones that are going to support the gut microbiome and improve metabolic health overall.

Diet holds immediate leverage. Eating habits that are based on nutrient-dense whole foods, healthy protein, and fiber help restore microbial balance and reduce inflammation. On the flip side, diets high in ultra-processed foods tend to push things further in the wrong direction, feeding into dysbiosis and metabolic dysfunction. Over time, those choices on daily dietary inputs either stabilize the system or continue to disrupt it.

If you want to make positive systemic changes, there’s also no getting around physical activity. It improves insulin sensitivity, reduces inflammation, supports healthier body composition, and takes pressure off organs like the liver, which are heavily impacted by metabolic dysfunction; that’s in addition to encouraging weight loss. Even modest, consistent movement moves the needle on your overall health trajectory.

When obesity has been long-standing, or BMI is severely high, it is highly likely that lifestyle changes alone are not going to be enough. This is an appropriate time to consider medical intervention.

Bariatric surgery is the gold standard for treating obesity and does more than just reduce weight. The resulting changes in metabolism, hormone signaling, and even the gut microbiome itself are measurable – insulin resistance improves, we see a reduction in systemic inflammation, and, when caught early, MASLD can be reversed.⁹

But if we are going to intervene at that level, we also need to understand what’s already happening in the liver. It isn’t always apparent or symptomatic, and it can influence surgical risk, recovery, and how the body responds metabolically after the procedure.

Treating obesity is a whole-body process. Yes, the goal is weight loss, but it’s also health improvement. This kind of evaluation is part of how we approach patient care at Strive. We’re looking at how the underlying systems are functioning before intervention, and how they respond after. If you have questions about surgery, lifestyle changes, or liver health before and after surgery, reach out to our team.

1. Micic, D., Polovina, S., Micic, D., & Macut, D. (2023). Obesity and Gut-Brain Axis. Acta endocrinologica (Bucharest, Romania : 2005), 19(2), 234–240. https://doi.org/10.4183/aeb.2023.234.
2. Asadi, A., Shadab Mehr, N., Mohamadi, M. H., Shokri, F., Heidary, M., Sadeghifard, N., & Khoshnood, S. (2022). Obesity and gut-microbiota-brain axis: A narrative review. Journal of clinical laboratory analysis, 36(5), e24420. https://doi.org/10.1002/jcla.24420.
3. Arellano-García, L., Portillo, M. P., Hadjihambi, A., Martínez, J. A., & Milton-Laskibar, I. (2026). The Gut–Brain Axis in Obesity: Mechanisms, Development, and Therapeutic Perspectives. Current Nutrition Reports, 15. https://doi.org/10.1007/s13668-026-00732-w.
4. Ahmed, F., Arshad, M. T., Maqsood, S., Ikram, A., & Gnedeka, K. T. (2025). Gut‐Brain Axis in Obesity: How Dietary Patterns Influence Psychological Well‐Being and Metabolic Health? Food Science & Nutrition, 13(7). https://doi.org/10.1002/fsn3.70689.
5. Nowak, K., Paluch, M., Cudzik, M., Syska, K., Gawlikowska, W., & Janczura, J. (2025). From steatosis to cirrhosis: the role of obesity in the progression of liver disease. Journal of diabetes and metabolic disorders, 24(2), 227. https://doi.org/10.1007/s40200-025-01754-x.
6. De Cól, J. P., de Lima, E. P., Pompeu, F. M., Cressoni Araújo, A., de Alvares Goulart, R., Bechara, M. D., Laurindo, L. F., Méndez-Sánchez, N., & Barbalho, S. M. (2024). Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. International Journal of Molecular Sciences, 25(7), 3694. https://doi.org/10.3390/ijms25073694.
7. Cen, C., Fan, Z., Ding, X., Tu, X., & Liu, Y. (2024). Associations between metabolic dysfunction-associated fatty liver disease, chronic kidney disease, and abdominal obesity: a national retrospective cohort study. Scientific Reports, 14. https://doi.org/10.1038/s41598-024-63386-0.
8. Elsabaawy, M. (2024). Liver at crossroads: unraveling the links between obesity, chronic liver diseases, and the mysterious obesity paradox. Clinical and Experimental Medicine, 24. https://doi.org/10.1007/s10238-024-01493-y.
9. Nowak, K., Paluch, M., Cudzik, M., Syska, K., Gawlikowska, W., & Janczura, J. (2025). From steatosis to cirrhosis: the role of obesity in the progression of liver disease. Journal of diabetes and metabolic disorders, 24(2), 227. https://doi.org/10.1007/s40200-025-01754-x.